Hospital Stocks Get Reprieve on Medicaid Spending, for Now
House Republicans decide to cap, rather than cut, controversial payment programs.
Fiscal Year: January - December
HCA Healthcare, Inc. (HCA), listed on the NYSE, has a market capitalization of $96.86B. As of May 20, 2025, the stock is trading at $386.89 per share, offering investors a clear view of its current market value. HCA Healthcare, Inc. is a prominent player in the industry sector, attracting both institutional and retail investors due to its performance and potential.
With a P/E ratio of 17.22, investors can assess the stock's valuation in comparison to its earnings. A P/E ratio is a crucial indicator for value investors, showing whether the stock is over or undervalued relative to its current earnings. HCA Healthcare, Inc. also offers a dividend yield of 0.74%, making it an attractive option for income-focused investors who seek regular dividends.
Our Discounted Cash Flow (DCF) analysis reveals that HCA Healthcare, Inc. (HCA) may be overvalued compared to its intrinsic worth. However, to see the exact DCF fair value, please Login or Upgrade for access.
The proprietary SS Score for HCA Healthcare, Inc. is a unique metric that analyzes the company's financial health and growth potential. The score takes into account critical factors such as revenue growth, net income, free cash flow (FCF) compound annual growth rate (CAGR), the trend of shares outstanding, and the debt-to-FCF ratio. This helps investors to make a more informed decision, as an undervalued stock might still have poor financial fundamentals.
To view the detailed SS Score for HCA Healthcare, Inc., Login or Upgrade for access.
The Price to Free Cash Flow (P/FCF) ratio for HCA Healthcare, Inc. is 18.81, offering insights into how much investors are paying for the company's free cash flow. A lower P/FCF ratio typically suggests that the stock is undervalued, while a higher ratio may indicate overvaluation.
In summary, HCA Healthcare, Inc. (HCA) has shown consistent financial performance, as illustrated by the financial charts above, which track its revenue growth, net income, free cash flow, and shares outstanding over the past several years. These metrics provide investors with key insights into the company's past and projected future performance. Investors should use the SS Score alongside the DCF Fair Value to make better-informed decisions about whether to buy or hold the stock.
*This analysis is for informational purposes only and does not constitute investment advice. Always read the company's 10-K filings and do your own research before making any investment decisions.
Whether HCA Healthcare, Inc. (HCA) is a good stock to buy depends on various factors, including its financial health, market conditions, and your investment strategy. Our analysis indicates that the stock may be overvalued compared to its intrinsic value. However, it is important to assess the SS Score and review the company's fundamentals before making any investment decisions.
The fair value of HCA Healthcare, Inc. (HCA) is determined through our Discounted Cash Flow (DCF) analysis. This value represents the intrinsic worth of the stock based on its expected future cash flows. To view the specific fair value, consider subscribing to our service for complete access.
The SS Score is a proprietary financial quality metric that assesses factors such as revenue growth, net income, free cash flow growth, and debt levels. It helps investors evaluate the overall financial health of HCA Healthcare, Inc.. To access the full SS Score, consider upgrading your subscription.
HCA Healthcare, Inc. is a significant player in the industry sector, with a market capitalization of $96.86B and a competitive P/E ratio of 17.22. Investors should compare these metrics with industry peers to gauge whether HCA Healthcare, Inc. is outperforming or underperforming within its sector.
House Republicans decide to cap, rather than cut, controversial payment programs.
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) is scheduled to present at the following healthcare conferences: May 13, 2025 at 9:20am PT at the Bank of America 2025 Healthcare Co...
I track 50 high-quality dividend growth stocks to identify opportune investments, updating valuation ratings daily to focus on attractive opportunities. Despite a market sell-off, my investable univer...
HCA Healthcare, Inc. (NYSE:HCA) Q1 2025 Earnings Conference Call April 25, 2025 10:00 AM ET Company Participants Frank Morgan - Vice President of Investor Relations Sam Hazen - Chief Executive Office...
Hospital operator HCA Healthcare said on Friday its first-quarter profit rose nearly 9%, as more people underwent elective procedures and sought medical care due to a rise in flu cases.
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the first quarter ended March 31, 2025. Key first quarter metrics (all percentag...
I believe HCA Healthcare is currently undervalued, especially after a recent 20.9% share price drop, making it a compelling 'buy' candidate. HCA Healthcare's financial performance has been solid, with...
NASHVILLE, Tenn. & ORANGE, Calif. & BOSTON--(BUSINESS WIRE)--Two large multi-state studies funded by the National Institutes of Health and led by the University of California, Irvine, Harvard Pilgrim ...
The stock market doesn't react well to uncertainty. And the daily headlines about new tariffs being placed on U.S. imports and possible negotiations with trading partners to do away with tariffs have ...
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that it has been named on Fortune's 2025 World's Most Admired Comp...
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast: What: HCA Healthcare, Inc. 1Q 2025 Earnings Call When: Friday, April 25, 2025 at 9:00 AM Central (1...
HCA Healthcare shares have gained 5% over the past year, with potential Medicaid cuts posing a modest future risk to revenue. Despite potential Medicaid cuts, HCA's relatively low Medicaid exposure (1...
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that Monica Cintado has been appointed as senior vice president of...
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that the HCA Healthcare Foundation, through its Healthier Tomorrow...
I present a list of 17 companies with upcoming dividend increases, highlighting those with over 10% increases and an average streak length of 11 years. My investment strategy focuses on buying, holdin...
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that 100 of its hospitals have been recognized as 2025 Patient Saf...
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that it has been recognized as one of the 2025 World's Most Ethica...
I track 50 high-quality dividend stocks, updating their valuations daily to identify Strong Buy, Buy, Hold, and Trim opportunities based on historical free cash flow trends. Today, I will highlight 9 ...
Infrastructure portfolio remained flat in Q4 but achieved its strongest calendar year in three years, outperforming its benchmark. Rising interest rates impacted REITs and utilities, while natural gas...
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA), is scheduled to present virtually at the following healthcare conferences: March 4, 2025 at 1:50pm ET at TD Cowen's 45th Annual Hea...
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced that its wholly owned subsidiary, HCA Inc., proposes to offer senior notes, subject to market and other consideratio...
Trump has pledged to protect Social Security and Medicare throughout his campaign, one analyst noted, but this was the first time he added Medicaid to the list.
Cincinnati, Ohio, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Ensemble, the nation's leading revenue cycle managed services company for healthcare organizations, is pleased to announce that Bill Rutherford, for...
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that 49 of its hospitals were named on the 2025 Healthgrades Ameri...
Andrew Mok, Barclays director of equity research, joins CNBC's 'The Exchange' to discuss why healthcare may offer opportunity as tech stocks are under pressure from China competition.
Below estimates were sourced from SimplyWallSt and are intended for educational purposes only as a baseline for the analysis.
Year | FCF Estimate | % | # Analysts |
---|---|---|---|
2025 | 6.26B | Analyst x5 | |
2026 | 6.17B | -1.47% | Analyst x5 |
2027 | 7.19B | 16.46% | Analyst x3 |
2028 | 8.03B | 11.70% | Analyst x1 |
2029 | 8.45B | 5.23% | Analyst x1 |
2030 | 8.71B | 3.08% | Est @3.1% |
2031 | 8.95B | 2.77% | Est @2.8% |
2032 | 9.18B | 2.57% | Est @2.6% |
2033 | 9.38B | 2.25% | Est @2.3% |
2034 | 9.59B | 2.16% | Est @2.2% |
Below are the FCF estimates with the discount factor and the calculated present value with the terminal value that led the results above.
Year | FCF | Discount Factor | PV of Future FCF |
---|---|---|---|
2023A | 4.69B | 1.00 | 4.69B |
2024A | 5.64B | 1.00 | 5.64B |
2025E | 6.26B | 1.09 | 5.75B |
2026E | 6.17B | 1.19 | 5.20B |
2027E | 7.19B | 1.29 | 5.55B |
2028E | 8.03B | 1.41 | 5.69B |
2029E | 8.45B | 1.54 | 5.50B |
2030E | 8.71B | 1.67 | 5.20B |
2031E | 8.95B | 1.82 | 4.91B |
2032E | 9.18B | 1.99 | 4.62B |
2033E | 9.38B | 2.17 | 4.33B |
2034E | 9.59B | 2.36 | 4.06B |
Terminal | 152.06B | 2.36 | 64.46B |
The information given by Studying Stocks and provided in the web and/or mobile applications (Platforms) is only factual information and should not be considered financial advice.
Any information contained in this website has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
When creating an account, you acknowledge that you are:
We retain the right to cancel your account for any reason, or refuse your account creation request.
The information on our Platforms is not comprehensive and is intended to provide a summary of the subject matter covered. While we use all reasonable attempts to ensure the accuracy and completeness of the data and information on our Platforms, to the extent permitted by law, we make no warranty regarding the information on these Platforms. You should monitor any changes to the information contained on these Platforms.
Furthermore we make no commitments in regards to the minimum amount of uptime that our platforms will maintain, although we will make ever reasonable attempt to ensure that the platforms are operational. Therefore, any reference of "latest", "current" and related words about the financial data presented here may not be up to date with the financial markets or represent reality of the information.
We are not liable to you or anyone else if interference with or damage to your computer systems occurs in connection with the use of these Platforms or a linked website. You must take your own precautions to ensure that whatever you select for your use from our Platforms is free of viruses or anything else (such as worms or Trojan horses) that may interfere with or damage the operations of your computer systems.
We may, from time to time and without notice, change or add to the Platforms (including the Terms) or the information, products or services described in it. However, we do not undertake to keep the Platforms updated. We are not liable to you or anyone else if errors occur in the information or the Platforms is not up-to-date.
Our Platforms may contain links to websites operated by third parties. Those links are provided for convenience and may not remain current or be maintained. Unless expressly stated otherwise, we do not endorse and are not responsible for the content on those linked websites and have no control over or rights in those linked websites.
These Platforms are for your personal, non-commercial use only. You may not modify, copy, distribute, transmit, display, perform, reproduce, publish, license, commercially exploit, create derivative works from, transfer, or sell any Content, software, products or services contained within these Platforms. You may not use these Platforms, or any of its Content, to further any commercial purpose, including any advertising or advertising revenue generation activity on your own website.
You must not do any act that we would deem to be inappropriate, is unlawful or is prohibited by any laws applicable to these Platforms, including but not limited to:
If we allow you to post any information to our Platforms, we have the right to take down this information at our sole discretion and without notice.
To the maximum extent permitted by law, we make no warranties or representations about these Platforms or the Content, including but not limited to warranties or representations that they will be complete, accurate or up-to-date, that access will be uninterrupted or error-free or free from viruses, or that these Platforms will be secure.
We reserve the right to restrict, suspend or terminate without notice your access to these Platforms, any Content, or any feature of these Platforms at any time without notice and we will not be responsible for any loss, cost, damage or liability that may arise as a result.
To the maximum extent permitted by law, in no event shall we be liable for any direct and indirect loss, damage or expense – irrespective of the manner in which it occurs – which may be suffered due to your use of our Platforms and/or the information or materials contained on it, or as a result of the inaccessibility of these Platforms and/or the fact that certain information or materials contained on it are incorrect, incomplete or not up-to-date.
This website utilises cookies. If you do not have cookies enabled in your web browser some functions of the site may not work as intended.